Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification

Annals of Oncology

Volumn 23, Issue 1, 2012, Pages 159-166

  Matasar, M J ^a,b   Shi, W ^b   Silberstien, J ^b   Lin, O ^b   Busam, K J ^b   Teruya Feldstein, J ^b   Filippa, D A ^b   Zelenetz, A D ^a   Noy, A ^a  

^a Lymphoma Service   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Lymphoma; Pathology; Second opinion

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CONTROLLED STUDY; DISEASE CLASSIFICATION; ETHNICITY; FEMALE; HEALTH CARE QUALITY; HODGKIN DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SEX RATIO; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

EID: 84855169947     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr029     Document Type: Article

References (18)

1. Sheehan WW, Rappaport H. Morphological criteria in the classification of the malignant lymphomas. Proc Natl Cancer Conf 1970; 6: 59-71.
2. Bettini R, Chelazzi G. Prognostic value of the Kiel classification of malignant non-Hodgkin's lymphomas. Tumori 1979; 65: 207-213.
3. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112-2135.
4. Classification of non-Hodgkin's lymphomas. Reproducibility of major classification systems. NCI non-Hodgkin's Classification Project Writing Committee. Cancer 1985; 55: 91-95.
5. Harris NL, Jaffe ES, Diebold J et al. Lymphoma classification-from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol 2000; 11 (Suppl 1): 3-10.
6. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 2000; 13: 193-207.
7. Swerdlow SH, Campo E, Harris NL et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC 2008.
8. Turner JJ, Hughes AM, Kricker A et al. Use of the WHO lymphoma classification in a population-based epidemiological study. Ann Oncol 2004; 15: 631-637.
9. Lester JF, Dojcinov SD, Attanoos RL et al. The clinical impact of expert pathological review on lymphoma management: a regional experience. Br J Haematol 2003; 123: 463-468.
10. Wetherington RW, Cooper HS, Al-Saleem T et al. Clinical significance of performing immunohistochemistry on cases with a previous diagnosis of cancer coming to a national comprehensive cancer center for treatment or second opinion. Am J Surg Pathol 2002; 26: 1222-1230.
11. Glaser SL, Dorfman RF, Clarke CA. Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry: interobserver reliability and impact on incidence and survival rates. Cancer 2001; 92: 218-224.
12. Kronz JD, Westra WH, Epstein JI. Mandatory second opinion surgical pathology at a large referral hospital. Cancer 1999; 86: 2426-2435.
13. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. Blood 1997; 89: 3909-3918.
14. Kukreti V, Patterson B, Callum J et al. Pathology the gold standard-a retrospective analysis of discordant "second-opinion" lymphoma pathology and its impact on patient care. ASH Annual Meeting Abstracts 2006; 108: 348.
15. LaCasce AS, Kho ME, Friedberg JW et al. Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol 2008; 26: 5107-5112.
16. Zelenetz AD, Hoppe RT. NCCN: non-Hodgkin's lymphoma. Cancer Control 2001; 8: 102-113.
17. NCCN practice guidelines for Hodgkin's disease. National Comprehensive Cancer Network. Oncology (Williston Park) 1999; 13: 78-110.
18. Morton LM, Wang SS, Devesa SS et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-276.